Parul Jain
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Parul Jain has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Amita Jain
All India Institute of Medical Sciences, Rae Bareli, Uttar Pradesh, India
3 shared publications Faisal Abbas
Department of Microbiology, King George’s Medical University, Lucknow, India
2 shared publicationsManu Singh
Department of Microbiology, King George’s Medical University, Lucknow, India
2 shared publicationsRashmi Ratnam
Department of Respiratory Medicine, King George’s Medical University, Lucknow, India
2 shared publicationsUrmila Singh
Department of Microbiology, King George’s Medical University, Lucknow, India
2 shared publications- Vimala Venkatesh
Department of Microbiology, King George's Medical University, Lucknow, India
2 shared publications
Latest Publications
- 22 April 2026
- Published by Springer Nature in Infection
- p. 1-9
Assessing fluoroquinolone resistance in Mycobacterium tuberculosis using nanopore sequencing: concordance with established diagnostic methods
Introduction Fluoroquinolones (FQs) are key components of World Health Organization (WHO)-recommended regimens for multidrug-resistant tuberculosis (MDR-TB). Accurate detection of FQ resistance is essential for optimizing treatment. This study evaluated the concordance between the Second-Line Line Probe Assay (SL-LPA) and Liquid Culture Drug Susceptibility Testing (LC-DST) for detecting FQ resistance in Mycobacterium tuberculosis isolates. Methods In this retrospective study, 1402 non-duplicate clinical isolates of MDR TB were tested using SL-LPA and LC-DST at a reference laboratory. Genotypic resistance was identified through mutations in the gyrA and gyrB genes identified by SL-LPA, while phenotypic resistance was determined using MGIT-based LC-DST at critical concentrations for fluoroquinolones. Targeted nanopore sequencing was performed on a subset of isolates with discordant molecular and phenotypic results to investigate resistance-associated mutations. Results SL-LPA detected FQ resistance in 907 (64.7%) isolates, whereas LC-DST identified resistance in 852 (60.8%) isolates. Using LC-DST as the reference standard, SL-LPA showed a sensitivity of 93.2%, specificity of 98.6%, positive predictive value of 99.2%, and negative predictive value of 88.7%. Overall concordance between the two methods was observed in 1292 (92.2%) isolates. Discordant results occurred in 110 (7.8%) isolates, mainly involving low-level resistance mutations or inferred resistance due to missing wild-type bands on SL-LPA. Nanopore sequencing of 15 discordant isolates identified high-confidence mutations (Asp94Tyr, Asp94Gly, Asp94Asn) and interim or low-confidence mutations (Ala90Val, Ser91Pro, Asp94Ala, gyrB Asn499Asp, Asp461Asn). Conclusion SL-LPA demonstrates excellent specificity and positive predictive value for detecting FQ resistance; however, discordance associated with low-confidence mutations and heteroresistance highlights the importance of integrating molecular assays with phenotypic DST and sequencing to improve MDR-TB resistance detection and guide treatment decisions.
- 22 April 2026
- Published by Springer Nature in Infection
- p. 1-9
Assessing fluoroquinolone resistance in Mycobacterium tuberculosis using nanopore sequencing: concordance with established diagnostic methods
Introduction Fluoroquinolones (FQs) are key components of World Health Organization (WHO)-recommended regimens for multidrug-resistant tuberculosis (MDR-TB). Accurate detection of FQ resistance is essential for optimizing treatment. This study evaluated the concordance between the Second-Line Line Probe Assay (SL-LPA) and Liquid Culture Drug Susceptibility Testing (LC-DST) for detecting FQ resistance in Mycobacterium tuberculosis isolates. Methods In this retrospective study, 1402 non-duplicate clinical isolates of MDR TB were tested using SL-LPA and LC-DST at a reference laboratory. Genotypic resistance was identified through mutations in the gyrA and gyrB genes identified by SL-LPA, while phenotypic resistance was determined using MGIT-based LC-DST at critical concentrations for fluoroquinolones. Targeted nanopore sequencing was performed on a subset of isolates with discordant molecular and phenotypic results to investigate resistance-associated mutations. Results SL-LPA detected FQ resistance in 907 (64.7%) isolates, whereas LC-DST identified resistance in 852 (60.8%) isolates. Using LC-DST as the reference standard, SL-LPA showed a sensitivity of 93.2%, specificity of 98.6%, positive predictive value of 99.2%, and negative predictive value of 88.7%. Overall concordance between the two methods was observed in 1292 (92.2%) isolates. Discordant results occurred in 110 (7.8%) isolates, mainly involving low-level resistance mutations or inferred resistance due to missing wild-type bands on SL-LPA. Nanopore sequencing of 15 discordant isolates identified high-confidence mutations (Asp94Tyr, Asp94Gly, Asp94Asn) and interim or low-confidence mutations (Ala90Val, Ser91Pro, Asp94Ala, gyrB Asn499Asp, Asp461Asn). Conclusion SL-LPA demonstrates excellent specificity and positive predictive value for detecting FQ resistance; however, discordance associated with low-confidence mutations and heteroresistance highlights the importance of integrating molecular assays with phenotypic DST and sequencing to improve MDR-TB resistance detection and guide treatment decisions.
- Open Access
- 17 April 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1)
Epidemiology of geriatric tuberculosis: a five-year retrospective study from a tertiary care hospital in India
Ageing affects the clinical presentation of diseases due to associated comorbidities, often leading to diagnostic imprecision and specialized treatment nee
- 17 April 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26 (1)
Open AccessEpidemiology of geriatric tuberculosis: a five-year retrospective study from a tertiary care hospital in India
Ageing affects the clinical presentation of diseases due to associated comorbidities, often leading to diagnostic imprecision and specialized treatment nee
- Open Access
- 1 August 2025
- Published by Microbiology Society in Access Microbiology
- Vol. 7 (8) , 000787.v4
A hospital-based observational study on HIV-TB co-infection
Background. Human immunodeficiency virus (HIV) is the major cause of failure to reach targets of tuberculosis (TB) control in settings with high HIV loads. TB, on the other hand, enhances the progression of HIV infection to AIDS. This study was done to understand the epidemiological and clinical profile of HIV-TB co-infected patients and to study the impact of TB on the recovery of CD4 counts. Methodology. An observational study was conducted in which of the 573 patients newly diagnosed with HIV infection and enrolled at the antiretroviral therapy (ART) centre, King George’s Medical University, Lucknow, between May 2021 and June 2022, 80 patients who also had newly diagnosed TB were included. These HIV-TB co-infected patients were analysed for demographic factors. Also, clusters of differentiation 4 (CD4) counts were done at the time of enrolment on ART and then later, ~6 to 8 months of recieving ART and anti-tubercular treatment (ATT) initiation. For comparison, of the 493 HIV-only patients, 50 age- and gender-matched consecutive patients for whom baseline and follow-up CD4 counts were available were enrolled as controls. The change from baseline CD4 count was calculated using a paired t-test and Wilcoxon signed rank test. Results. In the present study, among HIV-TB co-infected patients, baseline CD4 levels were 194.52±162.27, and follow-up CD4 levels were 285.09±170.33. A statistically significant increment of 90.57±165.60 in mean CD4 levels was observed (t=4.019; Pt=4.626; PConclusion. Though significant rise in CD4 counts was observed in both HIV-TB co-infected patients and HIV-only patients after 6 to 8 months of appropriate therapy, the rise was significantly higher among the HIV-only group as compared to the HIV-TB co-infected group.
- 1 August 2025
- Published by Microbiology Society in Access Microbiology
- Vol. 7 (8) , 000787.v4
Open AccessA hospital-based observational study on HIV-TB co-infection
Background. Human immunodeficiency virus (HIV) is the major cause of failure to reach targets of tuberculosis (TB) control in settings with high HIV loads. TB, on the other hand, enhances the progression of HIV infection to AIDS. This study was done to understand the epidemiological and clinical profile of HIV-TB co-infected patients and to study the impact of TB on the recovery of CD4 counts. Methodology. An observational study was conducted in which of the 573 patients newly diagnosed with HIV infection and enrolled at the antiretroviral therapy (ART) centre, King George’s Medical University, Lucknow, between May 2021 and June 2022, 80 patients who also had newly diagnosed TB were included. These HIV-TB co-infected patients were analysed for demographic factors. Also, clusters of differentiation 4 (CD4) counts were done at the time of enrolment on ART and then later, ~6 to 8 months of recieving ART and anti-tubercular treatment (ATT) initiation. For comparison, of the 493 HIV-only patients, 50 age- and gender-matched consecutive patients for whom baseline and follow-up CD4 counts were available were enrolled as controls. The change from baseline CD4 count was calculated using a paired t-test and Wilcoxon signed rank test. Results. In the present study, among HIV-TB co-infected patients, baseline CD4 levels were 194.52±162.27, and follow-up CD4 levels were 285.09±170.33. A statistically significant increment of 90.57±165.60 in mean CD4 levels was observed (t=4.019; Pt=4.626; PConclusion. Though significant rise in CD4 counts was observed in both HIV-TB co-infected patients and HIV-only patients after 6 to 8 months of appropriate therapy, the rise was significantly higher among the HIV-only group as compared to the HIV-TB co-infected group.
- Open Access
- 13 May 2024
- Published by Springer Nature in Research Square
Treatment of Mycobacterium tuberculosis infected macrophages with Rifabutin loaded β-glucan microparticles induces macroautophagy mediated bacillary killing
This study aims to assess the therapeutic efficacy of Rifabutin-loaded β-glucan particles (DYDGP) in targeting Mycobacterium tuberculosis (M.tb.) within host macrophage cells. Drug-loaded β-glucan microparticles were prepared using rifabutin for evaluating their therapeutic potential against in-vitro M.tb. infection in host macrophage cells. Our results demonstrate that DYDGP significantly enhances intracellular ROS generation at 30 minutes and 24 hours post-treatment compared to blank (YDGP) particles in the presence of NOX-2 inhibitors. Additionally, DYDGP promotes phago-lysosomal maturation and exhibits better cytoprotective function within M.tb. infected macrophages up to 24 hours post-treatment. Furthermore, our study indicates that DYDGP has the potential to induce autophagy within M.tb. infected macrophages, as evidenced by dansylcadvarine and immunofluorescence studies, along with LC-3 and NOX-2 protein expression analyses. Enhanced immunotherapeutic efficacy is crucial for combating M.tb, including multidrug-resistant (MDR) strains, within host macrophage cells. Colony forming unit studies confirm that DYDGP particles exhibit better immunotherapeutic potential compared to blank and pure drugs, suggesting they could serve as a promising alternative for host-directed adjunct therapies against M.tb. infections. These findings highlight the potential of DYDGP in improving therapeutic outcomes and combating drug-resistant M.tb. strains within host cells, contributing to the development of effective immunotherapeutic strategies against tuberculosis.
- 13 May 2024
- Published by Springer Nature in Research Square
Open AccessTreatment of Mycobacterium tuberculosis infected macrophages with Rifabutin loaded β-glucan microparticles induces macroautophagy mediated bacillary killing
This study aims to assess the therapeutic efficacy of Rifabutin-loaded β-glucan particles (DYDGP) in targeting Mycobacterium tuberculosis (M.tb.) within host macrophage cells. Drug-loaded β-glucan microparticles were prepared using rifabutin for evaluating their therapeutic potential against in-vitro M.tb. infection in host macrophage cells. Our results demonstrate that DYDGP significantly enhances intracellular ROS generation at 30 minutes and 24 hours post-treatment compared to blank (YDGP) particles in the presence of NOX-2 inhibitors. Additionally, DYDGP promotes phago-lysosomal maturation and exhibits better cytoprotective function within M.tb. infected macrophages up to 24 hours post-treatment. Furthermore, our study indicates that DYDGP has the potential to induce autophagy within M.tb. infected macrophages, as evidenced by dansylcadvarine and immunofluorescence studies, along with LC-3 and NOX-2 protein expression analyses. Enhanced immunotherapeutic efficacy is crucial for combating M.tb, including multidrug-resistant (MDR) strains, within host macrophage cells. Colony forming unit studies confirm that DYDGP particles exhibit better immunotherapeutic potential compared to blank and pure drugs, suggesting they could serve as a promising alternative for host-directed adjunct therapies against M.tb. infections. These findings highlight the potential of DYDGP in improving therapeutic outcomes and combating drug-resistant M.tb. strains within host cells, contributing to the development of effective immunotherapeutic strategies against tuberculosis.
- 5 January 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 106 (1) , 168-173
Prevalence of Dengue, Chikungunya, and Zika Viruses in Febrile Pregnant Women: An Observational Study at a Tertiary Care Hospital in North India
: Dengue virus (DENV), chikungunya virus (CHIKV), and Zika virus (ZIKV) are arboviruses that can affect maternal and fetal outcome if acquired during pregnancy. This study was done to estimate the positivity of DENV, CHIKV, and ZIKV in febrile pregnant women attending a tertiary care hospital in north India. Symptomatic pregnant women were tested for these viruses by IgM ELISA and/or by Trioplex real-time polymerase chain reaction. Their symptoms and laboratory parameters were recorded and were followed up till delivery to know their immediate delivery outcome. Of 104 women tested, 50 (48.1%) were positive for viral markers. Of these, evidence of infection by DENV, CHIKV, and both was found in 34 (32.7%), 10 (9.6%), and 6 (5.8%), respectively. ZIKV was not detected in any woman. Maximum DENV positivity occurred in the third trimester of pregnancy and in women residing in urban than rural areas. Chills and rigors, arthralgia, retro-orbital pain, anemia, and vaginal bleeding were more commonly associated with DENV positivity. Backache, arthralgia, jaundice, and vaginal bleeding were more common in CHIKV positives but the difference between positives and nonpositives regarding these symptoms was not statistically significant. Dengue infections were associated with more frequent hospitalizations (OR = 8.38, 95% confidence intervals [CI] = 3.29–21.30) and mortality (OR = 19.0, 95% CI = 1.01–357.10). Hence, to conclude, in India wherever possible, all symptomatic pregnant women should be screened for DENV, CHIKV, and ZIKV as part of sentinel surveillance for ZIKV.
- 5 January 2022
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 106 (1) , 168-173
Prevalence of Dengue, Chikungunya, and Zika Viruses in Febrile Pregnant Women: An Observational Study at a Tertiary Care Hospital in North India
: Dengue virus (DENV), chikungunya virus (CHIKV), and Zika virus (ZIKV) are arboviruses that can affect maternal and fetal outcome if acquired during pregnancy. This study was done to estimate the positivity of DENV, CHIKV, and ZIKV in febrile pregnant women attending a tertiary care hospital in north India. Symptomatic pregnant women were tested for these viruses by IgM ELISA and/or by Trioplex real-time polymerase chain reaction. Their symptoms and laboratory parameters were recorded and were followed up till delivery to know their immediate delivery outcome. Of 104 women tested, 50 (48.1%) were positive for viral markers. Of these, evidence of infection by DENV, CHIKV, and both was found in 34 (32.7%), 10 (9.6%), and 6 (5.8%), respectively. ZIKV was not detected in any woman. Maximum DENV positivity occurred in the third trimester of pregnancy and in women residing in urban than rural areas. Chills and rigors, arthralgia, retro-orbital pain, anemia, and vaginal bleeding were more commonly associated with DENV positivity. Backache, arthralgia, jaundice, and vaginal bleeding were more common in CHIKV positives but the difference between positives and nonpositives regarding these symptoms was not statistically significant. Dengue infections were associated with more frequent hospitalizations (OR = 8.38, 95% confidence intervals [CI] = 3.29–21.30) and mortality (OR = 19.0, 95% CI = 1.01–357.10). Hence, to conclude, in India wherever possible, all symptomatic pregnant women should be screened for DENV, CHIKV, and ZIKV as part of sentinel surveillance for ZIKV.
- Open Access
- 1 January 2021
- Published by KLE Academy of Higher Education and Research in Indian Journal of Health Sciences and Biomedical Research KLEU
- Vol. 14 (2) , 292
Severe acute respiratory syndrome coronavirus 2: Oncology-related perceptions
- 1 January 2021
- Published by KLE Academy of Higher Education and Research in Indian Journal of Health Sciences and Biomedical Research KLEU
- Vol. 14 (2) , 292
Open AccessSevere acute respiratory syndrome coronavirus 2: Oncology-related perceptions
- 1 July 2020
- Published by Elsevier in Medical Journal Armed Forces India
- Vol. 76 (3) , 361-363
Severe acute respiratory illness pandemics: coronavirus disease 2019 and other viral etiologies in the 21st century
- 1 July 2020
- Published by Elsevier in Medical Journal Armed Forces India
- Vol. 76 (3) , 361-363
Severe acute respiratory illness pandemics: coronavirus disease 2019 and other viral etiologies in the 21st century
- 26 September 2013
- Published by Springer Nature
- p. 53-74
Waterborne Viral Gastroenteritis: An Introduction to Common Agents
Acute gastroenteritis is among the most common illnesses of human beings, and its associated morbidity and mortality are greatest among those at the extremes of age; children and elderly. During the 1970s, several viruses were associated with this syndrome, which are now known to be caused mainly by viruses belonging to four distinct families—rotaviruses, caliciviruses, astroviruses, and adenoviruses. Other viruses, such as the toroviruses, picobirnaviruses, coronavirus, and enterovirus 22, may play a role as well. Transmission by food or water has been documented for astroviruses, caliciviruses, rotaviruses, and norovirus. In developing countries, gastroenteritis is a common cause of death in children <5 years, while deaths from diarrhea are less common, much illness leads to hospitalization or doctor visits. Laboratory confirmation of waterborne illness is based on demonstration of virus particles or antigen in stool, detection of viral nucleic acid in stool, or demonstration of a rise in specific antibody to the virus. Newer methods for syndrome surveillance of acute viral gastroenteritis are being developed like multiplex real-time reverse transcriptase PCRs. Application of these more sensitive methods to detect and characterize individual agents is just beginning, but has already opened up new avenues to reassess their disease burden, examine their molecular epidemiology, and consider new directions for their prevention and control through vaccination, improvements in water quality, and sanitary practices.
- 26 September 2013
- Published by Springer Nature
- p. 53-74
Waterborne Viral Gastroenteritis: An Introduction to Common Agents
Acute gastroenteritis is among the most common illnesses of human beings, and its associated morbidity and mortality are greatest among those at the extremes of age; children and elderly. During the 1970s, several viruses were associated with this syndrome, which are now known to be caused mainly by viruses belonging to four distinct families—rotaviruses, caliciviruses, astroviruses, and adenoviruses. Other viruses, such as the toroviruses, picobirnaviruses, coronavirus, and enterovirus 22, may play a role as well. Transmission by food or water has been documented for astroviruses, caliciviruses, rotaviruses, and norovirus. In developing countries, gastroenteritis is a common cause of death in children <5 years, while deaths from diarrhea are less common, much illness leads to hospitalization or doctor visits. Laboratory confirmation of waterborne illness is based on demonstration of virus particles or antigen in stool, detection of viral nucleic acid in stool, or demonstration of a rise in specific antibody to the virus. Newer methods for syndrome surveillance of acute viral gastroenteritis are being developed like multiplex real-time reverse transcriptase PCRs. Application of these more sensitive methods to detect and characterize individual agents is just beginning, but has already opened up new avenues to reassess their disease burden, examine their molecular epidemiology, and consider new directions for their prevention and control through vaccination, improvements in water quality, and sanitary practices.